| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1097/00002030-199003000-00001 |
| P953 | full work available at URL | http://journals.lww.com/00002030-199003000-00001 |
| P698 | PubMed publication ID | 1693514 |
| P2093 | author name string | F. Plata | |
| B. D. Walker | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunology | Q101929 |
| cytotoxicity | Q246181 | ||
| P304 | page(s) | 177-184 | |
| P577 | publication date | 1990-03-01 | |
| P1433 | published in | AIDS | Q4651863 |
| P1476 | title | Cytotoxic T lymphocytes against HIV | |
| P478 | volume | 4 |
| Q40049315 | A CD4+ cytotoxic T-lymphocyte clone to a conserved epitope on human immunodeficiency virus type 1 p24: cytotoxic activity and secretion of interleukin-2 and interleukin-6 |
| Q26851165 | A brief history of the global effort to develop a preventive HIV vaccine |
| Q44818812 | A chain section containing epitopes for cytotoxic T, B and helper T cells within a highly conserved region found in the human immunodeficiency virus type 1 Gag protein |
| Q73358372 | A clearer distinction between HIV-1 paired isolates from peripheral blood mononuclear cells of asymptomatic carriers with and without CD8+ T-cells at nef rather than env V3 loci |
| Q34356962 | A soluble factor(s) secreted from CD8(+) T lymphocytes inhibits human immunodeficiency virus type 1 replication through STAT1 activation |
| Q41567634 | Allo-antigen stimulated CD8+ T-cells suppress NF-κB and Ets-1 DNA binding activity, and inhibit phosphorylated NF-κB p65 nuclear localization in CD4+ T-cells. |
| Q36366846 | Autoreactive cytotoxic T lymphocytes in human immunodeficiency virus type 1-infected subjects |
| Q45750675 | Booster immunization of HIV-1 negative volunteers with HGP-30 vaccine induces protection against HIV-1 virus challenge in SCID mice |
| Q35860387 | Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice |
| Q67598997 | CD8 T lymphocyte subset markers and HIV infection |
| Q33835440 | CD8(+) lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: implications for vaccine design and testing |
| Q33804193 | CD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription |
| Q34585299 | CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription |
| Q34423446 | Challenges in the design of a T cell vaccine in the context of HIV-1 diversity |
| Q45074152 | Changes in natural immunity during the course of HIV-1 infection |
| Q36680806 | Characterization of the antigenic domains of the major core protein (p26) of equine infectious anemia virus |
| Q36648079 | Cross-reactive lysis of human targets infected with prototypic and clinical human immunodeficiency virus type 1 (HIV-1) strains by murine anti-HIV-1 IIIB env-specific cytotoxic T lymphocytes |
| Q72065860 | Cytotoxic T lymphocyte activity and CD8 subpopulations in children at risk of HIV infection |
| Q34194927 | Cytotoxic and proliferative T cell responses in HIV-1-infected Macaca nemestrina |
| Q35833022 | Cytotoxic effector cell granules recognized by the monoclonal antibody TIA-1 are present in CD8+ lymphocytes in lymph nodes of human immunodeficiency virus-1-infected patients |
| Q73816109 | Detection of IgE anti-parvovirus B19 and increased CD23+ B cells in parvovirus B19 infection: relation to Th2 cytokines |
| Q35831103 | Detection, localization, and quantitation of HIV-associated antigens in intestinal biopsies from patients with HIV |
| Q35818772 | Discovery of another anti-HIV protein in the search for the CD8+ cell anti-HIV Factor |
| Q33842057 | Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity |
| Q28369395 | Effect of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine on establishment of human immunodeficiency virus type 1 infection in cultured CD8+ lymphocytes |
| Q64066295 | Effective Suppression of HIV-1 Replication by Cytotoxic T Lymphocytes Specific for Pol Epitopes in Conserved Mosaic Vaccine Immunogens |
| Q45750927 | Enhanced CD8+ T cell response to HIV-1 env by combined immunization with influenza and vaccinia virus recombinants |
| Q45783114 | Enhanced activation of human T cell clones specific for virus-like particles expressing the HIV V3 loop in the presence of HIV V3 loop-specific polyclonal antibodies |
| Q36797826 | Episodic occurrence of antibodies against the bovine leukemia virus Rex protein during the course of infection in sheep |
| Q39553434 | Evidence for circulating activated cytotoxic T cells in HIV-infected subjects before the onset of opportunistic infections |
| Q73221913 | Flt3 ligand enhances the immunogenicity of a gag-based HIV-1 vaccine |
| Q36640687 | Gag-specific cytotoxic T lymphocytes from human immunodeficiency virus type 1-infected individuals: Gag epitopes are clustered in three regions of the p24gag protein |
| Q40922824 | Generation of CD4+ and CD8+ T-cell clones from PBLs of HIV-1 infected subjects using herpesvirus saimiri |
| Q35749755 | HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype |
| Q40584444 | HIV, 'an evolving species'. Roles of cellular activation and co-infections |
| Q33646313 | High major histocompatibility complex-unrestricted lysis of simian immunodeficiency virus envelope-expressing cells predisposes macaques to rapid AIDS progression |
| Q36645820 | Human immunodeficiency virus type 1-specific cytotoxic T lymphocytes release gamma interferon, tumor necrosis factor alpha (TNF-alpha), and TNF-beta when they encounter their target antigens |
| Q36231550 | Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies |
| Q63707151 | In vivo persistence of a HIV-1-encoded HLA-B27-restricted cytotoxic T lymphocyte epitope despite specificin vitro reactivity |
| Q36627098 | Increase in soluble CD4 binding to and CD4-induced dissociation of gp120 from virions correlates with infectivity of human immunodeficiency virus type 1. |
| Q67542096 | Increased LAK activity against HIV-infected cell lines in HIV-1+ individuals |
| Q74458973 | Induction of cross clade reactive specific antibodies in mice by conjugates of HGP-30 (peptide analog of HIV-1(SF2) p17) and peptide segments of human beta-2-microglobulin or MHC II beta chain |
| Q33935668 | Induction of feline immunodeficiency virus-specific cytolytic T-cell responses from experimentally infected cats |
| Q71634193 | Inhibition of HIV replication by CD8+ T cells correlates with CD4 counts and clinical stage of disease |
| Q41062967 | Interleukin-2 and human immunodeficiency virus infection: pathogenic mechanisms and potential for immunologic enhancement |
| Q73498987 | Lymphocyte subset changes between 3 and 15 months of age in infants born to HIV‐seropositive women in South Africa |
| Q46864964 | Non-cytolytic CD8 T-cell anti-HIV responses in primary HIV-1 infection |
| Q36013559 | On the HIV nef gene product |
| Q41528992 | Parainfluenza type 1 virus-infected cells are killed by both CD8+ and CD4+ cytotoxic T cell precursors |
| Q93081405 | Plasma Membrane-Associated Restriction Factors and Their Counteraction by HIV-1 Accessory Proteins |
| Q43585283 | Preclinical and clinical studies on immunogenicity and safety of the HIV-1 p17-based synthetic peptide AIDS vaccine — HGP-30-KLH |
| Q36592108 | Significant enlargement of a specific subset of CD3+CD8+ peripheral blood leukocytes mediating cytotoxic T-lymphocyte activity during human immunodeficiency virus infection. |
| Q72106483 | Stress-associated reductions of cytotoxic T lymphocytes and natural killer cells in asymptomatic HIV infection |
| Q39553428 | Subset markers of CD8(+) cells and their relation to enhanced cytotoxic T-cell activity during human immunodeficiency virus infection |
| Q34593086 | Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies |
| Q24650854 | T helper cell activation and human retroviral pathogenesis |
| Q78116560 | The T cell receptor repertoire of CD8+CD28- T lymphocytes is dominated by expanded clones that persist over time |
| Q34619970 | The advantage of early recognition of HIV-infected cells by cytotoxic T-lymphocytes |
| Q43903235 | The expansion of CD8 lymphocytes using T cell receptor variable gene products during HIV infection. |
| Q40063883 | Three epitopic peptides of the simian immunodeficiency virus Nef protein recognized by macaque cytolytic T lymphocytes |
| Q36953142 | Vaccinia virus recombinants expressing chimeric proteins of human immunodeficiency virus and gamma interferon are attenuated for nude mice |
| Q24645815 | Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection |
Search more.